Drugs / hMG-IBSA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00464607 | Dec 2001 → Apr 2005 | infertility disorder | IBSA Institut Biochimique SA | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hMG-IBSA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00464607 ↗ |
| Known as | MERIONAL | “clinical efficacy of MERIONAL® (hMG-IBSA) Administered Subcutaneously Versus MERIONALâ Administered Intramuscularly” NCT00464607 ↗ |
| Route | Subcutaneous | “Administered Subcutaneously” NCT00464607 ↗ |